Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.56 HKD | -1.24% | -22.56% | -54.28% |
Jun. 03 | Oncosil Medical Treats 200th Pancreatic Cancer Patient with Proprietary Device | MT |
May. 02 | OncoSil Medical Raises AU$5.3 Million under Entitlement Offer | MT |
Sales 2024 * | 321M 44.35M 347M | Sales 2025 * | 426M 58.75M 459M | Capitalization | 3.23B 446M 3.48B |
---|---|---|---|---|---|
Net income 2024 * | -117M -16.14M -126M | Net income 2025 * | -34M -4.69M -36.65M | EV / Sales 2024 * | 7.18 x |
Net cash position 2024 * | 922M 127M 994M | Net cash position 2025 * | 931M 128M 1B | EV / Sales 2025 * | 5.4 x |
P/E ratio 2024 * |
-27.4
x | P/E ratio 2025 * |
-93.8
x | Employees | 124 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.91% |
1 day | -1.24% | ||
1 week | -22.56% | ||
Current month | -22.56% | ||
1 month | -19.07% | ||
3 months | -37.53% | ||
6 months | -44.01% | ||
Current year | -54.28% |
Managers | Title | Age | Since |
---|---|---|---|
Zhiyong Pan
CEO | Chief Executive Officer | 47 | Jan. 11 |
Davin Wu
DFI | Director of Finance/CFO | 39 | 22-03-08 |
Jon Randle
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chun Shun Ko
BRD | Director/Board Member | 72 | - |
Shing Yim Chau
BRD | Director/Board Member | 60 | 18-04-15 |
Ka Chun Tiu
BRD | Director/Board Member | 47 | 19-07-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 5.56 | -1.24% | 1,065,000 |
24-06-06 | 5.63 | +3.49% | 3,428,500 |
24-06-05 | 5.44 | -9.33% | 6,733,000 |
24-06-04 | 6 | -9.77% | 6,015,500 |
24-06-03 | 6.65 | -7.38% | 3,148,392 |
Delayed Quote Hong Kong S.E., June 07, 2024 at 04:09 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-54.28% | 446M | |
+40.39% | 59.96B | |
+76.65% | 10.65B | |
+47.27% | 1.54B | |
+62.41% | 506M | |
+163.35% | 432M | |
-51.76% | 336M | |
-65.85% | 119M | |
0.00% | 118M | |
-33.90% | 92.53M |
- Stock Market
- Equities
- 863 Stock